MENU
Aim higher

BlyMAT

Development of a fully human bispecific therapeutic antibody for T cell mediated eradication of Acute Myeloid Leukemia

Start date: 
01-03-2012
Project Duration: 
35months
Technological Area: 
Biology / Biotechnology
Market Area: 
Therapeutic